MAPK1 and breast carcinoma: However, miR-550a gradually decreased during breast cancer initiation and progression and miR-550a-3p exerts its tumor-suppressor role by directly repressing ERK1 and ERK2, which reduce progression and metastasis of breast cancer cell [17].